Cargando…

Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes

The screening and testing of extracts against a variety of pharmacological targets in order to benefit from the immense natural chemical diversity is a concern in many laboratories worldwide. And several successes have been recorded in finding new actives in natural products, some of which have beco...

Descripción completa

Detalles Bibliográficos
Autores principales: Lautié, Emmanuelle, Russo, Olivier, Ducrot, Pierre, Boutin, Jean A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154113/
https://www.ncbi.nlm.nih.gov/pubmed/32317969
http://dx.doi.org/10.3389/fphar.2020.00397
_version_ 1783521767878295552
author Lautié, Emmanuelle
Russo, Olivier
Ducrot, Pierre
Boutin, Jean A.
author_facet Lautié, Emmanuelle
Russo, Olivier
Ducrot, Pierre
Boutin, Jean A.
author_sort Lautié, Emmanuelle
collection PubMed
description The screening and testing of extracts against a variety of pharmacological targets in order to benefit from the immense natural chemical diversity is a concern in many laboratories worldwide. And several successes have been recorded in finding new actives in natural products, some of which have become new drugs or new sources of inspiration for drugs. But in view of the vast amount of research on the subject, it is surprising that not more drug candidates were found. In our view, it is fundamental to reflect upon the approaches of such drug discovery programs and the technical processes that are used, along with their inherent difficulties and biases. Based on an extensive survey of recent publications, we discuss the origin and the variety of natural chemical diversity as well as the strategies to having the potential to embrace this diversity. It seemed to us that some of the difficulties of the area could be related with the technical approaches that are used, so the present review begins with synthetizing some of the more used discovery strategies, exemplifying some key points, in order to address some of their limitations. It appears that one of the challenges of natural product-based drug discovery programs should be an easier access to renewable sources of plant-derived products. Maximizing the use of the data together with the exploration of chemical diversity while working on reasonable supply of natural product-based entities could be a way to answer this challenge. We suggested alternative ways to access and explore part of this chemical diversity with in vitro cultures. We also reinforced how important it was organizing and making available this worldwide knowledge in an “inventory” of natural products and their sources. And finally, we focused on strategies based on synthetic biology and syntheses that allow reaching industrial scale supply. Approaches based on the opportunities lying in untapped natural plant chemical diversity are also considered.
format Online
Article
Text
id pubmed-7154113
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71541132020-04-21 Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes Lautié, Emmanuelle Russo, Olivier Ducrot, Pierre Boutin, Jean A. Front Pharmacol Pharmacology The screening and testing of extracts against a variety of pharmacological targets in order to benefit from the immense natural chemical diversity is a concern in many laboratories worldwide. And several successes have been recorded in finding new actives in natural products, some of which have become new drugs or new sources of inspiration for drugs. But in view of the vast amount of research on the subject, it is surprising that not more drug candidates were found. In our view, it is fundamental to reflect upon the approaches of such drug discovery programs and the technical processes that are used, along with their inherent difficulties and biases. Based on an extensive survey of recent publications, we discuss the origin and the variety of natural chemical diversity as well as the strategies to having the potential to embrace this diversity. It seemed to us that some of the difficulties of the area could be related with the technical approaches that are used, so the present review begins with synthetizing some of the more used discovery strategies, exemplifying some key points, in order to address some of their limitations. It appears that one of the challenges of natural product-based drug discovery programs should be an easier access to renewable sources of plant-derived products. Maximizing the use of the data together with the exploration of chemical diversity while working on reasonable supply of natural product-based entities could be a way to answer this challenge. We suggested alternative ways to access and explore part of this chemical diversity with in vitro cultures. We also reinforced how important it was organizing and making available this worldwide knowledge in an “inventory” of natural products and their sources. And finally, we focused on strategies based on synthetic biology and syntheses that allow reaching industrial scale supply. Approaches based on the opportunities lying in untapped natural plant chemical diversity are also considered. Frontiers Media S.A. 2020-04-07 /pmc/articles/PMC7154113/ /pubmed/32317969 http://dx.doi.org/10.3389/fphar.2020.00397 Text en Copyright © 2020 Lautié, Russo, Ducrot and Boutin http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Lautié, Emmanuelle
Russo, Olivier
Ducrot, Pierre
Boutin, Jean A.
Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes
title Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes
title_full Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes
title_fullStr Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes
title_full_unstemmed Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes
title_short Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes
title_sort unraveling plant natural chemical diversity for drug discovery purposes
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154113/
https://www.ncbi.nlm.nih.gov/pubmed/32317969
http://dx.doi.org/10.3389/fphar.2020.00397
work_keys_str_mv AT lautieemmanuelle unravelingplantnaturalchemicaldiversityfordrugdiscoverypurposes
AT russoolivier unravelingplantnaturalchemicaldiversityfordrugdiscoverypurposes
AT ducrotpierre unravelingplantnaturalchemicaldiversityfordrugdiscoverypurposes
AT boutinjeana unravelingplantnaturalchemicaldiversityfordrugdiscoverypurposes